The Global Challenge of Antimicrobial resistance (AMR)

Antimicrobial resistance (AMR) represents a global public health threat.

AMR is a dynamic phenomenon, microorganisms evolve leading to loss of susceptibility to antimicrobial drugs. As a result, infections persist and may spread to others.

Over the years, use and misuse of antimicrobials, lack of infection control practises, global travel and trade, have all contributed to the acceleration of AMR. Consequently, an increasing number of infectious diseases are becoming difficult to manage, with dramatic health and economic impact.

Although over the last decade resistant infections have also been seen in the community, multidrug resistant infections are frequently associated with the hospital health-care setting, affecting the most frail patients. With resistance on the rise, we stand to lose the immense ground we have gained in in the medical field over the last century.

(ref. WHO website)


Innovation & Research

We are highly committed to developing effective solutions to address the global threat associated with antimicrobial resistance. Discover more about our R&D projects in the anti-infectives area.

Read More